Global Neurological Biomarkers Market Growth 2025-2031
The global Neurological Biomarkers market size is predicted to grow from US$ 8498 million in 2025 to US$ 17180 million in 2031; it is expected to grow at a CAGR of 12.4% from 2025 to 2031.
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
LP Information, Inc. (LPI) ' newest research report, the “Neurological Biomarkers Industry Forecast” looks at past sales and reviews total world Neurological Biomarkers sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurological Biomarkers sales for 2025 through 2031. With Neurological Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Neurological Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Biomarkers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Biomarkers.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Biomarkers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segmentation by Application:
Diagnostics
Drug Discovery
Personalized Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Key Questions Addressed in this Report
What is the 10-year outlook for the global Neurological Biomarkers market?
What factors are driving Neurological Biomarkers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurological Biomarkers market opportunities vary by end market size?
How does Neurological Biomarkers break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.